Innocoll has signed a license and distribution agreement with Biomet 3i for its CollaCare dental products.
Under the deal, Biomet 3i will distribute the products to all global territories outside of China and ASEAN.
Developed using Innocoll's proprietary collagen based technologies, the dental products are comprised of a lyophilized matrix of purified type I collagen available in various easy-to-apply formats including sponge, tape, cone, and powder.
Having intrinsic haemostatic properties, the collagen-based products when applied topically over the wound controls bleeding in three minutes, claims Innocoll.
The porous structure also enables absorption of fluids and upon hydration the dressings are conformable to the shape of the wound.
The products are indicated for topical hemostasis and for the management to clean oral wounds such as dental and periodontal surgical wounds, extraction sites, traumatic oral wounds, denture sores, oral ulcers, and burns.
The products, which are currently approved for sale in the US and Europe, are also expected to serve as temporary wound dressings during prolonged dental procedures.
Innocoll president and CEO Michael Myers said, "This is another significant step for Innocoll as we expand the reach of our product portfolio and further demonstrates the broad applicability of our technology in a diverse range of surgical and wound healing settings."